The US government has agreed to provide a whopping $483 million in federal funding to propel Modera’s coronavirus vaccine to FDA approval and ramp up production capacity. The award is something of a gamble, coming before data from an ongoing…
1,000 foreign firms mull production in India, 300 actively pursue plan as ‘Exit China’ mantra grows
These companies see India as an alternate manufacturing hub and have taken up their proposals across various levels of the government, including central government departments, Indian missions abroad and state industry departments KEY HIGHLIGHTS 1,000 foreign firms are planning to…
Israeli COVID-19 treatment with 100% survival rate tested on US patient
After one week, six critically ill patients in Israel survived. Four of them showed improvement in respiratory parameters. Israeli-based Pluristem has treated its first American patient suffering from COVID-19 complications under the country’s compassionate use program. The news comes…
Study Suggests Intermittent Social Distancing Could Become Necessary Against COVID-19 Until 2022
Social distancing has become the new norm in the attempt to prevent the spread of COVID-19, and that norm could become a mainstay of life for the next couple years, a new study suggests. Based on predictions of recurring outbreaks…
AZ, Lilly join efforts to develop drugs for COVID-19
AstraZeneca and Eli Lilly have joined the ranks of drugmakers around the world trying to repurpose existing drugs for use in severely-ill COVID-19 patients as the number of cases worldwide approaches 2 million. A trial of Lilly’s JAK inhibitor…
First study of Gilead’s remdesivir in COVID-19 reveals little
Two-thirds of coronavirus patients treated with Gilead’s antiviral drug remdesivir seemed to get a clinical benefit from the drug in a just-published study – but it’s still far too early to say if it is effective. That is the preliminary…
WHO: More than 70 COVID-19 Vaccines are in Development, Three in Clinical Trials
More than 2 million people have been diagnosed with COVID-19, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global pandemic. According to the World Health Organization (WHO), there are now more…
GSK and Sanofi Join Forces to Develop a COVID-19 Vaccine
As the world continues to wait with bated breath for a vaccine against COVID-19, GlaxoSmithKline and Sanofi have joined forces to develop an adjuvanted vaccine for COVID-19. The two companies are eying the second half of this year to begin…
Med comms agency 90TEN acquired by Envision Pharma Group
90TEN has been acquired by Envision Pharma Group in a move its new parent company says will deepen and diversify its offering. The London-based healthcare communications agency (whose team are pictured above) will retain its brand, while bringing its behavioral…
EMA clears compassionate use of Gilead’s remdesivir for COVID-19
The EU drugs regulator says Gilead Sciences’ antiviral drug remdesivir should be made available for people seriously ill with COVID-19, despite limited data on its efficacy. The EMA’s human medicines committee (CHMP) says the antiviral drug can be used on…
